Understanding the Impacts of Presystemic Metabolism on the Human Oral Bioavailability of Chemicals
- 31 July 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 58 (32) , 14135-14145
Abstract
Animal-free new approach methods promote chemical assessments based on the comparison between in vitro bioactivity and human internal concentrations, which necessitates a dependable knowledge of human oral bioavailability, i.e., the fraction of an orally ingested chemical that escapes from presystemic ("first-pass") metabolic processes and eventually enters systemic circulation. Using a physiologically based toxicokinetic model, we show how human oral bioavailability is impacted by presystemic metabolism within the gut lumen, gut wall, and liver and how this impact differs among chemicals with various permeability and stability properties. Our results highlight the gut lumen as a primary site of presystemic metabolism of certain chemicals, such as di-2-ethylhexyl phthalate (DEHP), for which the gut lumen may even exceed the liver in importance of presystemic metabolism due to these metabolic processes occurring in sequence. For chemicals with low transmembrane permeability and low stability, metabolism within the gut lumen is the most remarkable of the three presystemic metabolic processes. Notably, for chemicals that undergo substantial metabolism within the gut lumen, where the metabolites have high permeability, there is a notable discrepancy between the "theoretical bioavailability" (bioavailability of the unchanged parent compound) and the "apparent bioavailability" in measurement practices (bioavailability inferred from measured metabolites). Our work highlights the importance of considering presystemic metabolism, notably within the gut lumen, in human exposure and toxicokinetic modeling.Keywords
Funding Information
- U.S. Environmental Protection Agency (840033, 840684)
This publication has 59 references indexed in Scilit:
- Phthalic acid esters in grains, vegetables, and fruits: concentration, distribution, composition, bio-accessibility, and dietary exposureEnvironmental Science and Pollution Research, 2022
- Toward improved models for predicting bioconcentration of well-metabolized compounds by rainbow trout using measured rates of in vitro intrinsic clearanceEnvironmental Toxicology and Chemistry, 2013
- Absorption and Drug Development2012
- New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHPArchives of Toxicology, 2005
- Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHPArchives of Toxicology, 2004
- Metabolism of Omeprazole by Gut Flora in RatsJournal of Pharmaceutical Sciences, 1995
- Inability of the human fecal microflora to metabolize the nonabsorbable fat substitute, olestraJournal of Industrial Microbiology and Biotechnology, 1994
- Lingual and gastric lipases: species differences in the origin of prepancreatic digestive lipases and in the localization of gastric lipaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- A theoretical examination of the effects of gut wall metabolism, hepatic elimination, and enterohepatic recycling on estimates of bioavailability and of hepatic blood flowJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Metabolism of Di-(2-ethylhexyl) phthalate by the contents of the alimentary tract of the ratFood and Cosmetics Toxicology, 1974